This study looked at the effect of dapagliflozin (Farxiga) on kidney disease in patients with type 2 diabetes. It found patients treated with dapagliflozin were significantly less likely to have a decline in kidney function.

This study investigated whether thiazolidinediones (TZDs) can help lower the risk of Parkinson’s disease (PD) in patients with type 2 diabetes (T2D). The authors concluded that TZDs were associated with a lower risk of PD in these patients.

This study examined whether urinary adiponectin can predict the progression of diabetic kidney disease.

This study investigated the effectiveness of the current management of type 1 diabetes.

This article summarizes a presentation on the treatment of autonomic diabetic neuropathy in the gut (gastroparesis). The presentation was given at the 2015 annual meeting of the European Association for the Study of Diabetes (EASD). The article concluded that the first goal of treatment is to tightly control blood sugar to prevent autonomic neuropathy from progressing.

This review examined the progress which has been made in recent years in developing immunotherapies for type 1 diabetes. 

This study examined whether Ly 2963016 insulin glargine is safe and effective in type 1 diabetics.

This study compared the accuracy of two continuous glucose monitoring systems for type 1 diabetes. 

The authors aimed to evaluate the relationship between age-related macular degeneration and diabetes. The authors concluded that diabetes was a risk factor for age-related macular degeneration (AMD) and the association was stronger in late AMD than earlier stages. 

The authors evaluated the prevalence of insulin-related hypoglycemia requiring emergency department visits, and the associated risk factors.